Related Experiment Video
Updated: Aug 13, 2026

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Dynamic incremental CT: effect of volume and concentration of contrast material and patient weight on hepatic
J P Heiken1, J A Brink, B L McClennan
1Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO 63110, USA.
Purpose:
To develop an individualized approach to the intravenous administration of contrast material for hepatic computed tomography (CT).
Materials And Methods:
Two hundred patients were randomized into eight protocols. Each group received different volumes and concentrations of contrast material. For each protocol, maximum hepatic enhancement (MHE) was calculated, with an adjustment for iodine dose and patient weight. The contrast enhancement index (CEI) and optimum scanning interval were calculated for hepatic enhancement thresholds of 10-60 HU.
Results:
The MHE calculated as a function of patient weight was 96 HU +/- 19 per gram of iodine per kilogram of body weight. CEIs obtained with a contrast material concentration of 240 mg of iodine per milliliter were inferior to those obtained with a concentration of 320 or 350 mg I/mL. At low enhancement thresholds, the volume of contrast material had a more important effect than the concentration on CEI and optimum scanning interval; at high thresholds, concentration had a more important effect.
Conclusion:
For a patient of known weight, one can calculate the iodine dose needed to provide a desired level of hepatic enhancement. Use of a contrast material with a concentration of 240 mg L/mL is not recommended for dynamic incremental hepatic CT, except in small patients (eg, those weighing less than 73 kg).
More Related Videos
09:32Time-Resolved, Dynamic Computed Tomography Angiography for Characterization of Aortic Endoleaks and Treatment Guidance via 2D-3D Fusion-Imaging
Published on: December 9, 2021
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Related Concept Videos
Radiological Investigation I: X-ray and CT
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Imaging Studies for Cardiovascular System V: CT
Imaging Studies III: Computed Tomography